Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02607 SH PHARMA
RTNominal up10.960 +0.440 (+4.183%)
Research Report

07/04/2020 17:34

{I-bank focus}Morgan ups Shanghai Pharma (02607) to HK$17.3

[ET Net News Agency, 7 April 2020] Morgan Stanley raised its target price for Shanghai
Pharmaceutical (SPH)(02607) to HK$17.3 from HK$17.1 and maintained its "equal-weight"
rating.
The research house said a business presence spanning the full healthcare value chain
should help SPH increase efficiencies and extract synergies via its integrated platform of
distribution-manufacturing-retail.
Morgan added that SPH should show stable growth from favorable macro tailwinds and M&A
opportunities that management is actively seeking. Shanghai government support for its
only healthcare SOE should help secure SPH's leading position in key coastal markets. (KL)

Back to Research Report

Remark: Real time quote last updated: 24/09/2024 15:27
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.